Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Medicine’s Wellcome Centre for Human Genetics (WHG) has received a Silver Engage Watermark from the National Co-ordinating Centre for Public Engagement (NCCPE) for its public engagement efforts.

Children engaging with science

The Engage Watermark is granted to higher education institutions in recognition of their strategic support for public engagement and their commitment to improving the support offered. The Engage Watermark has four levels of award: Bronze, Silver, Gold, and Platinum. The Silver Award is given to the institution that has made progress in addressing its level of support for public engagement and is using evidence and intelligence to focus its efforts and future plans.

WHG has a resourced programme of support that has been developed and expanded over many years. Purposeful public engagement activities at WHG prioritise the depth of impact over the scale of reach. Diversity from informing and inspiring broad audiences to listening deeply to particular patient communities is seen. WHG has emphasised the importance of aligning its public engagement work with that of the Centre for Personalised Medicine. Additionally, it contributes to the public engagement of the Nuffield Department of Medicine's communications and engagement strategy. WHG has used a very new strategy, mission and priorities to frame the future approach.

Prof John Todd, Professor of Precision Medicine and Director of the Wellcome Centre for Human Genetics said: ‘‘Public engagement is crucial for promoting scientific literacy, fostering public trust in science. Receiving the Silver Engage Watermark Award is a testament to the hard work and dedication of our team at the Wellcome Centre for Human Genetics. This award highlights our commitment to public engagement and encourages us to continue using our new strategy, mission, and priorities to guide our future approach. We look forward to working with NCCPE over the next three years and continue developing our practice and leadership in public engagement.’’

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

University of Oxford announces next-generation Ai initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI).

Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health

Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.